GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinew Pharma Inc (ROCO:6634) » Definitions » Growth Rank

Sinew Pharma (ROCO:6634) Growth Rank : 0 (As of May. 17, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sinew Pharma Growth Rank?

Sinew Pharma has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


Sinew Pharma Growth Rank Related Terms

Thank you for viewing the detailed overview of Sinew Pharma's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinew Pharma (ROCO:6634) Business Description

Traded in Other Exchanges
N/A
Address
C516, Building C, Number 99, Lane 130, Section 1, Yuanyuan Road, Nangang District, Taipei, TWN, 11571
Sinew Pharma Inc is a Taiwan based biopharmaceutical company. It focuses on integrated new drug research and development. The company produces liver disease treatment medicines, pain treatment drugs, animal medicines, and other products. Its product portfolio includes SNP-610, SNP-630, SNP-810, SNP-820, SNP-830 and SNP-840.

Sinew Pharma (ROCO:6634) Headlines

No Headlines